News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
June, 2025
June 2025
M T W T F S S
 1
2345678
9101112131415
16171819202122
23242526272829
30  
What can the EU do to strengthen women’s cancer rights? – European Cancer Organisation
European Cancer Organisation/LinkedIn
Feb 26, 2025, 16:32

What can the EU do to strengthen women’s cancer rights? – European Cancer Organisation

European Cancer Organisation shared a post on LinkedIn:

“What can the EU do to strengthen women’s cancer rights?

Heidi Ulrike Siller (European Institute for Women’s Health) and Alexia Fafara (European Women’s Lobby) will address the EU’s policy solutions to close the gap.

Join us on 6 March at the European Parliament!

Register today.”

Alexia Fafara cancer Heidi Ulrike Siller OncoDaily Oncology
Special Coverage
Insight
Jun 2, 2025, 07:20
Sergio Cifuentes: Structured exercise after adjuvant chemotherapy  for colon cancer
Blog
Jun 2, 2025, 07:08
Roupen Odabashian: Benchmarking LLM Performance on Breast Oncology Multiple-Choice Questions
Insight
Jun 2, 2025, 07:04
Ibrahim Halil Sahin: The ATOMIC trial is out!
Blog
Jun 2, 2025, 06:59
Armando Orlandi: Day 3 of ASCO25 - Key Breast Cancer Updates
Blog
Jun 2, 2025, 06:54
Sarah Cannon Research Institute - Skip Burris was Honored with Endowed ASCO-Conquer Cancer Award in His Name
Insight
Jun 2, 2025, 06:41
Martin Zapata Laguado: New players in the management of mRCC patients
Insight
Jun 2, 2025, 06:19
Martin Zapata Laguado: KN564 maintain benefit on OS in ccRCC
Science
Jun 2, 2025, 06:09
Gerard Mawhinney: 14-year review of the Oxford Spinal Sarcoma Service on primary spinal tumour care
Blog
Jun 2, 2025, 05:45
ABC Global Alliance President, Fatima Cardoso, received the prestigious 2025 Yvonne Award for Lifetime Achievement in Oncology
Oncolibrary
Jun 2, 2025, 05:43
ctDNA Analysis in the Phase 3 NIAGARA Trial: Perioperative Durvalumab with Neoadjuvant Chemotherapy in Muscle-Invasive Bladder Cancer
Science
Jun 2, 2025, 05:32
ALNEO Phase II Trial Highlights Promising Role of Perioperative Alectinib in Stage III Resectable ALK-Positive NSCLC
Science
Jun 2, 2025, 05:14
SAVANNAH Trial Highlights Synergistic Effect of Savolitinib and Osimertinib in EGFR-Mutant NSCLC with MET-Mediated Resistance